Compound Q&A

Are there alternatives to Dasatinib-d8 (CAS: 1132093-70-9) in synthesis?

Answer

Dasatinib-d8
Alternative reagents such as dasatinib-d4 and dasatinib-d6 are used as isotopically labeled analogs. Isomers like cis-dasatinib and trans-dasatinib may also be considered. Synthesizers often explore these options to achieve similar labeling or structural modifications.

About

English Name Dasatinib-d8
Molecular Formula C22H18ClD8N7O2S
Molecular Weight 496.07 g/mol
SMILES OCCN1C([2H])([2H])C([2H])([2H])N(C(C1([2H])[2H])([2H])[2H])c1cc(nc(n1)C)Nc1ncc(s1)C(=O)Nc1c(C)cccc1Cl
InChIKey ZBNZXTGUTAYRHI-COMRDEPKSA-N
Last Updated: 2025-12-29 23:19

Related Q&A

Compound Q&A

What regulatory guidelines apply to Dasatinib-d8 (CAS: 1132093-70-9)?

Dasatinib-d8 (CAS: 1132093-70-9) is regulated under GHS classification as a hazardous chemical. In t...

Compound Q&A

What is the market or research trend for Dasatinib-d8 (CAS: 1132093-70-9)?

The market for Dasatinib-d8 (CAS: 1132093-70-9) is growing due to its use in pharmaceutical research...

Compound Q&A

How should waste containing Dasatinib-d8 (CAS: 1132093-70-9) be handled?

Waste containing Dasatinib-d8 (CAS: 1132093-70-9) should be collected in a sealed, leak-proof contai...

Compound Q&A

What is 6-Methyl-7-oxabicyclo[4.1.0]heptan-2-one (CAS: 21889-89-4)?

6-Methyl-7-oxabicyclo[4.1.0]heptan-2-one is a cyclic ketone with a molecular for...

21889-89-46-Methyl-7-oxabicycl...
Compound Q&A

What is 4-[(6-Methyl-2-pyrazinyl)oxy]benzoic acid (CAS: 906353-00-2)?

4-[(6-Methyl-2-pyrazinyl)oxy]benzoic acid is a chemical compound with the CAS nu...

906353-00-24-[(6-Methyl-2-pyraz...
Compound Q&A

What is 2-(2-Pyridinyl)-1,3-propanediol (CAS: 49745-42-8)?

2-(2-Pyridinyl)-1,3-propanediol (CAS: 49745-42-8) is a colorless to slightly yel...

49745-42-82-(2-Pyridinyl)-1,3-...
Compound Q&A

What is 2-(6-Chloro-2-pyridinyl)-2-phenylacetonitrile (CAS: 24783-42-4)?

2-(6-Chloro-2-pyridinyl)-2-phenylacetonitrile is an organic compound with the CA...

24783-42-42-(6-Chloro-2-pyridi...